213 related articles for article (PubMed ID: 15543396)
1. Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene.
Barros AC; Muranaka EN; Mori LJ; Pelizon CH; Iriya K; Giocondo G; Pinotti JA
Rev Hosp Clin Fac Med Sao Paulo; 2004 Oct; 59(5):257-61. PubMed ID: 15543396
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats.
Alvarado A; Lopes AC; Faustino-Rocha AI; Cabrita AMS; Ferreira R; Oliveira PA; Colaço B
Pathol Res Pract; 2017 May; 213(5):441-446. PubMed ID: 28285967
[TBL] [Abstract][Full Text] [Related]
3. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
[TBL] [Abstract][Full Text] [Related]
4. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
5. Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats.
Rajakumar T; Pugalendhi P; Thilagavathi S
Chem Biol Interact; 2015 Apr; 231():35-43. PubMed ID: 25744308
[TBL] [Abstract][Full Text] [Related]
6. Charles River Sprague Dawley rats lack early age-dependent susceptibility to DMBA-induced mammary carcinogenesis.
Gear RB; Yan M; Schneider J; Succop P; Heffelfinger SC; Clegg DJ
Int J Biol Sci; 2007 Oct; 3(7):408-16. PubMed ID: 17940635
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of MNU and DMBA in mammary carcinogenesis and H-ras activation in female Sprague-Dawley rats.
Shirai K; Uemura Y; Fukumoto M; Tsukamoto T; Pascual R; Nandi S; Tsubura A
Cancer Lett; 1997 Nov; 120(1):87-93. PubMed ID: 9570390
[TBL] [Abstract][Full Text] [Related]
8. Effect of 13 week magnetic field exposures on DMBA-initiated mammary gland carcinomas in female Sprague-Dawley rats.
Anderson LE; Boorman GA; Morris JE; Sasser LB; Mann PC; Grumbein SL; Hailey JR; McNally A; Sills RC; Haseman JK
Carcinogenesis; 1999 Aug; 20(8):1615-20. PubMed ID: 10426815
[TBL] [Abstract][Full Text] [Related]
9. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
10. Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland.
Malejka-Giganti D; Bennett KK; Culp SJ; Beland FA; Shinozuka H; Bliss RL
Cancer Detect Prev; 2005; 29(4):338-47. PubMed ID: 16054776
[TBL] [Abstract][Full Text] [Related]
11. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50-Hz, 100-microT magnetic field: replication study.
Mevissen M; Häussler M; Lerchl A; Löscher W
J Toxicol Environ Health A; 1998 Mar; 53(5):401-18. PubMed ID: 9515942
[TBL] [Abstract][Full Text] [Related]
13. Effect of wheat bran fiber on the development of mammary tumors in female intact and ovariectomized rats treated with 7,12-dimethylbenz(a)anthracene and in mice with spontaneously developing mammary tumors.
Zile MH; Welsch CW; Welsch MA
Int J Cancer; 1998 Jan; 75(3):439-43. PubMed ID: 9455806
[TBL] [Abstract][Full Text] [Related]
14. Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats.
Diwan BA; Kasprzak KS; Anderson LM
Carcinogenesis; 1997 Sep; 18(9):1757-62. PubMed ID: 9328172
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of modeling effects of two different 7, 12-dimethylbenz[a] anthracene induced breast cancer models in tree shrew].
Mao AY; Chen MJ; Yang C; Ou C; Ye XQ; Qin QH; Mo M; Wei CY
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):346-350. PubMed ID: 31137167
[No Abstract] [Full Text] [Related]
16. Lymphocyte mutant frequency in relation to DNA adduct formation in rats treated with tumorigenic doses of the mammary gland carcinogen 7,12-dimethylbenz[a]anthracene.
Manjanatha MG; Lyn-Cook LE; Culp SJ; Beland FA; Heflich RH; Aidoo A
Mutat Res; 1996 Oct; 357(1-2):89-96. PubMed ID: 8876684
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive potential of genistein and daidzein in combination during 7,12-dimethylbenz[a]anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats.
Pugalendhi P; Manoharan S
Pak J Biol Sci; 2010 Mar; 13(6):279-86. PubMed ID: 20506715
[TBL] [Abstract][Full Text] [Related]
18. Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis.
De Jonage-Canonico MB; Lenoir V; Martin A; Scholler R; Kerdelhué B
Breast Cancer Res Treat; 2003 Jun; 79(3):365-77. PubMed ID: 12846421
[TBL] [Abstract][Full Text] [Related]
19. Induction of mammary tumors in aging rats by 7,12-dimethylbenz[a]anthracene: role of DNA synthesis during carcinogenesis.
Sinha DK; Dao TL
J Natl Cancer Inst; 1980 Mar; 64(3):519-21. PubMed ID: 6766511
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of carcinogenic potential of diuron in a rat mammary two-stage carcinogenesis model.
Grassi TF; Rodrigues MA; de Camargo JL; Barbisan LF
Toxicol Pathol; 2011 Apr; 39(3):486-95. PubMed ID: 21398560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
